Cancer Care

Primary Care Physicians May Be Key to Meeting the Growing Demand for Cancer Care

By

Radical improvements in diagnostic services, cancer education, and training, and policies that encourage integration between primary and specialist care, primary care doctors could hold the key to meeting the growing demand for cancer care.

Transfusion Indications for Patients With Cancer

Transfusion Indications for Patients With Cancer

In infrequent situations in which coagulation factor replacement is needed, plasma can be vital for patients with cancer. Granulocyte transfusions may sometimes be considered for recalcitrant infections in patients with neutropenia. This article summarizes the current clinical indications and uses of RBCs, plasma, and granulocytes.

CIO: Bacteria could be new agent in battle against cancer

CIO: Bacteria could be new agent in battle against cancer

A weakened strain of Clostridium novyi-NT bacteria killed cancer cells when injected into tumors, investigators reported.

Study reviews LMWH treatment for cancer-related deep vein thrombosis

Study reviews LMWH treatment for cancer-related deep vein thrombosis

Presence of residual vein thrombosis may help determine the optimal duration of anticoagulant therapy in cancer patients with deep vein thrombosis (DVT) of the lower limbs.

Those with HIV less likely to receive cancer treatment

Those with HIV less likely to receive cancer treatment

HIV-infected individuals with cancer are less likely to receive treatment, according to a study published online in the Journal of Clinical Oncology.

Can antihistamines be used to fight cancer?

Can antihistamines be used to fight cancer?

Researchers have found that as antihistamines do their job, they also interfere with the function of myeloid-derived suppressor cells—a type of cell known to hinder the body's ability to combat tumors.

ASTRO: Cancers that qualify for proton therapy limited

ASTRO: Cancers that qualify for proton therapy limited

Evidence to support reimbursement for proton-beam therapy remains limited to several relatively uncommon cancers.

Cancer patient demands rarely lead to unnecessary tests and treatments

By

Despite claims suggesting otherwise, inappropriate cancer patient demands are few and very rarely lead to unnecessary tests and treatments from their health care providers, according to new results.

Tumor tracking technique may improve outcomes for patients with lung cancer

By

A new tumor-tracking technique delivers higher levels of radiation to moving tumors while sparing healthy tissue in lung cancer patients. This technique is moving closer to the clinic.

Radiolabeled treatments may improve outcomes in advanced metastatic cancer

By

Radiolabeled agents are powerful tools to target and kill cancer cells. Three recent studies explore the benefits of adding radionuclide therapy when treating metastatic cancer.

Early discussion of end-of-life care leads to less aggressive treatment and more use of hospice

By

Patients with advanced cancer who discussed end-of-life care with their doctors earlier in the course of their illness had care that was less aggressive in their last month of life and were more likely to use hospice services.

Optimal dose of dasatinib determined for advanced, recurrent ovarian cancer

By

A phase I trial determined that dasatinib 150 mg daily is the optimum dose when dasatinib is combined with paclitaxel and carboplatin to treat patients with advanced or recurrent ovarian cancer.

Social barriers impact care of Hispanic children with cancer

By

Language barriers and the immigration status of caregivers appear to impact the care of Hispanic children with cancer and affect the experience of the families within the medical system.

Many cancer survivors face physical and mental health-related quality of life issues

By

More than a third of the 12.6 million cancer survivors in the United States have physical or mental health-related problems that jeopardize their overall health.

Noninvasive assay monitors treatment response in patients with metastatic prostate cancer

By

Certain analyses of cancer cells isolated from the blood could guide decisions about the ideal treatment for a patient with metastatic prostate cancer who has stopped responding to initial therapy.

Active surveillance is viable alternative to surgery for small kidney masses

By

Active surveillance of small kidney masses is a safe and effective alternative to immediate surgery. The overall and cancer specific survival rates are similar for both approaches.

Fit elderly patients with NSCLC should be considered for therapy

By

Fit elderly patients with non-small cell lung cancer (NSCLC) should be considered for salvage targeted therapy. Many physicians use age to decide what therapy to give their patients, since validated biomarkers to direct treatment decisions are lacking.

Veristrat predicts response but not survival benefit from NSCLC treatment

By

The plasma test VeriStrat can predict response but not survival benefit from erlotinib in patients with advanced non-small cell lung cancer (NSCLC).

New tool determines "readiness to die" of leukemia cells

By

A novel method has been developed to determine how ready acute myeloid leukemia (AML) cells are to die. This discovery may help to more effectively choose treatment options for patient with AML.

Patient navigation services improve time to diagnosis and care for vulnerable patients

By

For female patients with an abnormal breast or cervical cancer screening result, patient navigation services help to decrease the time to diagnosis and helps vulnerable populations get the care they need in a timely manner.

Rural colon cancer patients fare worse than urban patients

By

Patients who live in rural areas are more likely to receive late-stage diagnoses and to die from their colon cancer, and less likely to receive an early diagnosis, chemotherapy, or thorough surgical treatment, according to a recent study presented at the 2012 Annual Clinical Congress of the American College of Surgeons.

Race affects the likelihood of finding a suitable stem cell donor

By

Greater difficulty exists in finding matched, unrelated donors for nonwhite patients who are candidates for hematopoietic cell transplantation (HCT), according to a study by researchers at the Moffitt Cancer Center.

Understanding the impact of disparities on cancer care

Understanding the impact of disparities on cancer care

By

Learn how patients' perceptions of health care can have a significant influence on the effectiveness of cancer care and patient education.

Disparities in surgical management of thyroid cancer

By

ATA guidelines for well-differentiated thyroid cancer recommend therapeutic neck dissection when the disease is clinically involved or metastatic and prophylactic central neck dissection when tumors are advanced. Nonetheless, though these established guidelines are in place, the surgical management of cervical nodes varies greatly.

Cancer Survivors Uneasy With Primary Care Doctor Follow-Up

Cancer Survivors Uneasy With Primary Care Doctor Follow-Up

Survivors cite lack of cancer expertise, continuity of care as barriers to role of primary care doctors.

A clearer role for radiotherapy in high-risk melanoma

A clearer role for radiotherapy in high-risk melanoma

By

A new study suggests radiotherapy may hold clinical promise for the control of local lymph node bed recurrence of malignant melanoma.

MyCancerCircle creates a community of caregivers

MyCancerCircle creates a community of caregivers

People with cancer and their caregivers can turn to a new Web site to help answer the question from concerned relatives and friends, "What can I do to help?"

Cancer Medicine and Liability in the 21st Century

Cancer Medicine and Liability in the 21st Century

What are the best ways to combine good medical practice with good medico‑legal and legal practice in an era of 21st century cancer medicine?

Including palliative care at diagnosis is beneficial for patients with advanced cancer

Including palliative care at diagnosis is beneficial for patients with advanced cancer

By

ASCO recommends offering palliative care to all patients with metastatic or advanced cancer, ideally at diagnosis.

Cancer hospitalizations rated

The Agency for Healthcare Research and Quality (AHRQ) released Statistical Brief #125 Cancer Hospitalizations for Adults, 2009.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs